1. Home
  2. ATOS vs AOUT Comparison

ATOS vs AOUT Comparison

Compare ATOS & AOUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • AOUT
  • Stock Information
  • Founded
  • ATOS 2009
  • AOUT 2020
  • Country
  • ATOS United States
  • AOUT United States
  • Employees
  • ATOS N/A
  • AOUT N/A
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • AOUT Ordnance And Accessories
  • Sector
  • ATOS Health Care
  • AOUT Industrials
  • Exchange
  • ATOS Nasdaq
  • AOUT Nasdaq
  • Market Cap
  • ATOS 112.7M
  • AOUT 108.6M
  • IPO Year
  • ATOS 2012
  • AOUT N/A
  • Fundamental
  • Price
  • ATOS $1.01
  • AOUT $8.72
  • Analyst Decision
  • ATOS Strong Buy
  • AOUT Strong Buy
  • Analyst Count
  • ATOS 3
  • AOUT 1
  • Target Price
  • ATOS $6.25
  • AOUT $19.00
  • AVG Volume (30 Days)
  • ATOS 762.2K
  • AOUT 85.1K
  • Earning Date
  • ATOS 11-11-2025
  • AOUT 09-04-2025
  • Dividend Yield
  • ATOS N/A
  • AOUT N/A
  • EPS Growth
  • ATOS N/A
  • AOUT N/A
  • EPS
  • ATOS N/A
  • AOUT N/A
  • Revenue
  • ATOS N/A
  • AOUT $210,381,000.00
  • Revenue This Year
  • ATOS N/A
  • AOUT N/A
  • Revenue Next Year
  • ATOS N/A
  • AOUT $7.08
  • P/E Ratio
  • ATOS N/A
  • AOUT N/A
  • Revenue Growth
  • ATOS N/A
  • AOUT 5.56
  • 52 Week Low
  • ATOS $0.55
  • AOUT $8.10
  • 52 Week High
  • ATOS $1.66
  • AOUT $17.91
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 77.26
  • AOUT 45.15
  • Support Level
  • ATOS $0.81
  • AOUT $8.25
  • Resistance Level
  • ATOS $0.90
  • AOUT $8.87
  • Average True Range (ATR)
  • ATOS 0.04
  • AOUT 0.33
  • MACD
  • ATOS 0.02
  • AOUT 0.02
  • Stochastic Oscillator
  • ATOS 83.33
  • AOUT 54.65

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is engaged in the business of providing outdoor products and accessories for hunting, fishing, camping, shooting, and personal security and defense products. The company designs and produces products and accessories, including shooting supplies, rest, vaults, and other related accessories; premium sportsman knives and tools for fishing and hunting; land management tools for hunting preparedness; harvesting products for post-hunt or post-fishing activities; electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips; reloading, gunsmithing, and firearm cleaning supplies; and survival, camping, and emergency preparedness products.

Share on Social Networks: